A recent study showed that low-dose IL-2 selectively expanded Tregs and attenuated symptoms in mice with trinitrobenzene sulfonic acid/dinitrobenzene sulfonic acid (TNBS/DNBS)-induced colitis 24. This evidence concerns the gene IL2 and colitis.